When Is Antipsychotic Polypharmacy Supported by Research Evidence? Implications for QI

Author： Gören Jessica L.   Parks Joseph J.   Ghinassi Frank A.   Milton Celeste G.   Oldham John M.   Hernandez Pablo   Chan Jeffrey   Hermann Richard C.  

Publisher： Joint Commission Resources

ISSN： 1553-7250

Source： Joint Commission Journal on Quality and Patient Safety, Vol.34, Iss.10, 2008-10, pp. : 571-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs

By Valuck Robert J.   Morrato Elaine H.   Dodd Sheri   Oderda Gary   Haxby Dean G.   Allen Richard    

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2567-2576

Informa Healthcare

Access to resources Recommend Favorite

Antipsychotic Drugs: When and How to Withdraw Them?

By  

Psychotherapy and Psychosomatics, Vol. 75, Iss. 3, 2006-04 ,pp. : 133-138

Karger

Access to resources Recommend Favorite

Aspects affecting occupational therapists' reasoning when implementing research-based evidence in stroke rehabilitation

By Kristensen Hanne Kaae   Borg Tove   Hounsgaard L.  

Scandinavian Journal of Occupational Therapy, Vol. 19, Iss. 2, 2012-03 ,pp. : 118-131

Informa Healthcare

Access to resources Recommend Favorite

Research evidence

By  

Community Practitioner, Vol. 85, Iss. 3, 2012-03 ,pp. : 14-14

Community Practitioner

Access to resources Recommend Favorite

When is a Research Question Not a Research Question?

By Mayo Nancy E.   Asano Miho   Pamela Barbic Skye  

Journal of Rehabilitation Medicine, Vol. 45, Iss. 6, 2013-06 ,pp. : 513-518

Medical Journals Limited

Access to resources Recommend Favorite